First Tracks Biotherapeutics, Inc. (TRAX)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 2 signals for First Tracks Biotherapeutics, Inc.. Most notable: 2026-06-22: Filed 8-K disclosing material agreement; 2026-09-02: Ware J. Anthony (director) sold $1.8M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Large insider sale
    Ware J. Anthony (director) sold $1.8M of stock
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing material agreement, acquisition or disposition of assets, director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-09-15Orwin John AdirectorM1,3000$0
2026-09-02Ware J. AnthonydirectorM39,2655.74$225,381
2026-09-02Ware J. AnthonydirectorS39,26544.78$1,758,145
2026-06-15Jain RitadirectorM7,3300$0
2026-06-15Ware J. AnthonydirectorM6,0300$0
2026-06-15Schmid John P.directorM6,0300$0
2026-06-15Orwin John AdirectorM6,0300$0
2026-06-15Marquet MagdadirectorM6,0300$0
2026-06-15FENTON DENNIS MdirectorM6,0300$0
2026-06-15Jain RitadirectorM7,3300$0
2026-06-15Schmid John P.directorM6,0300$0
2026-06-15Orwin John AdirectorM6,0300$0
2026-06-15Ware J. AnthonydirectorM6,0300$0
2026-06-15Marquet MagdadirectorM6,0300$0
2026-06-15FENTON DENNIS MdirectorM6,0300$0
2026-04-20EcoR1 Capital, LLCten percent ownerS4,705,57513.81$64,983,991
2026-04-20ANAPTYSBIO, INCten percent ownerJ100——
2026-04-20EcoR1 Capital, LLCten percent ownerS4,705,57513.81$64,999,990

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings